(Total Views: 824)
Posted On: 07/20/2024 12:50:35 AM
Post# of 148870
WOW!!...Project End Date 30-June-2024
"This work would provide a safe and viable alternative to prevent vertical transmission of HIV-1 and support direct in vivo delivery of anti-HIV prophylactic modalities in infants"
_____________
The known Dr. Sasha $5m grant Cytodyn news:
July 11, 2022 :
https://www.cytodyn.com/newsroom/press-releas...ional-cure
July 25th, 2022:
Followed-up with the Infant study Award.
https://reporter.nih.gov/search/L2baW-idgEGE5...s/10497314
Could be a stunning report coming for Leronlimab, being the 1st stage of the project ended last month.
Outstanding!
"This work would provide a safe and viable alternative to prevent vertical transmission of HIV-1 and support direct in vivo delivery of anti-HIV prophylactic modalities in infants"
_____________
The known Dr. Sasha $5m grant Cytodyn news:
July 11, 2022 :
https://www.cytodyn.com/newsroom/press-releas...ional-cure
July 25th, 2022:
Followed-up with the Infant study Award.
https://reporter.nih.gov/search/L2baW-idgEGE5...s/10497314
Could be a stunning report coming for Leronlimab, being the 1st stage of the project ended last month.
Outstanding!
(13)
(0)
Scroll down for more posts ▼